DIA
IONS icon

Dana Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Dana Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
18,487
+461
+3% +$36.4K 0.04% 367
2025
Q4 		$1.43M Sell
18,026
-792
-4% -$59.6K 0.04% 358
2025
Q3 		$1.23M Buy
+18,818
New +$919K 0.04% 364

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dana Investment Advisors's IONS Position: Q1 2026 in Review

Dana Investment Advisors increased its Ionis Pharmaceuticals (IONS) stake by 2.6% in Q1 2026, buying an estimated $36.4K and bringing the position to 18,487 shares worth $1.39M. The position accounts for 0.04% of the portfolio, ranked #367.

Dana Investment Advisors first reported a position in IONS in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.43M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Dana Investment Advisors held 18,487 shares of Ionis Pharmaceuticals worth $1.39M as of Q1 2026.
  • Dana Investment Advisors bought 461 Ionis Pharmaceuticals shares in Q1 2026, an estimated $36.4K.
  • Ionis Pharmaceuticals made up 0.04% of Dana Investment Advisors's portfolio in Q1 2026, its #367 holding.
  • Dana Investment Advisors first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Dana Investment Advisors's Ionis Pharmaceuticals position peaked at $1.43M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Dana Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.